introduct
viral
respiratori
infect
may
precipit
acut
exacerb
copd
aecopd
howev
littl
known
viral
etiolog
relat
aecopd
asia
aim
studi
viral
etiolog
aecopd
hong
kong
method
patient
admit
acut
hospit
hong
kong
aecopd
recruit
prospect
may
april
nasopharyng
aspir
collect
assess
polymeras
chain
reaction
pcr
viral
cultur
spirometri
perform
stabl
phase
month
hospit
discharg
result
episod
aecopd
among
patient
mean
age
year
sd
men
mean
fev
predict
normal
fev
fvc
ratio
fiftyeight
episod
yield
posit
viral
pcr
result
virus
identifi
influenza
coronaviru
rhinoviru
influenza
b
respiratori
syncyti
viru
diagnost
yield
viral
identif
pcr
time
higher
base
convent
viral
cultur
rate
identifi
posit
viral
etiolog
pcr
similar
among
subject
fev
predict
normal
viral
infect
appear
effect
subsequ
readmiss
mortal
rate
studi
period
year
conclus
influenza
two
lessattend
virus
coronaviru
rhinoviru
common
etiolog
agent
patient
hospit
aecopd
hong
kong
consid
develop
diagnost
interven
strategi
pertain
aecopd
abbrevi
aecopd
acut
exacerb
copd
cxr
chest
radiograph
gold
global
initi
chronic
obstruct
lung
diseas
mdck
mardin
darbi
canin
kidney
npa
nasopharyng
aspir
nppv
noninvas
posit
pressur
ventil
pcr
polymeras
chain
reaction
rsv
respiratori
syncyti
viru
cute
exacerb
copd
aecopd
lead
signific
morbid
mortal
worldwid
previou
studi
shown
pulmonari
function
qualiti
life
advers
affect
frequent
exacerb
particularli
activ
smoker
hong
kong
copd
fifthlead
caus
death
account
least
public
hospit
acut
admiss
previous
shown
patient
hospit
aecopd
readmiss
rate
episod
wherea
mortal
rate
common
etiolog
factor
aecopd
includ
infect
air
pollut
withdraw
medic
chang
temperatur
etiolog
agent
may
vari
differ
geograph
locat
previous
conduct
prospect
studi
infecti
etiolog
relat
aecopd
hong
kong
identif
virus
base
viral
cultur
nasopharyng
aspir
npa
blood
serolog
howev
method
lack
sensit
comparison
newer
techniqu
polymeras
chain
reaction
pcr
viru
identif
aim
studi
assess
prospect
viral
etiolog
subject
hospit
aecopd
use
pcr
method
npa
specimen
addit
explor
relationship
viral
identif
clinic
paramet
length
stay
hospit
need
noninvas
posit
pressur
ventil
nppv
readmiss
mortal
subsequ
month
lung
function
recoveri
influenza
vaccin
preced
year
patient
admit
princ
wale
hospit
aecopd
may
april
recruit
studi
everi
altern
day
aecopd
defin
patient
background
copd
present
least
two
major
symptom
increas
dyspnea
increas
sputum
purul
increas
sputum
volum
one
major
one
minor
symptom
nasal
dischargecongest
wheez
sore
throat
cough
least
consecut
day
inform
written
consent
obtain
subject
studi
approv
research
ethic
committe
chines
univers
hong
kong
demograph
data
length
hospit
stay
patient
aecopd
record
comorbid
condit
note
score
charlson
index
score
charlson
index
rang
higher
score
indic
number
sever
coexist
ill
addit
chest
radiograph
cxr
assess
investig
respiratori
physician
without
pneumon
chang
cxr
includ
analysi
studi
use
nppv
invas
mechan
ventil
icu
admiss
record
npa
obtain
cathet
aspir
posterior
nasal
pharyng
space
via
nostril
patient
sit
posit
describ
previou
studi
npa
collect
ml
viral
transport
medium
contain
gentamycin
mgml
penicillinstreptomycin
iu
gml
fungizon
mgml
process
usual
within
h
viral
cultur
pcr
assay
briefli
aspir
centrifug
min
cell
pellet
wash
phosphatebuff
salin
solut
coat
onto
glass
slide
supernat
inocul
onto
rhesu
monkey
kidney
human
laryng
carcinoma
mardin
darbi
canin
kidney
mdck
human
embryon
lung
fibroblast
cell
monolay
cell
cultur
incub
except
mdck
incub
cell
monolay
examin
daili
cytopath
effect
day
incub
hemadsorpt
test
mdck
monolay
perform
suspici
cytopath
effect
observ
hemadsorpt
test
result
posit
presenc
viru
growth
confirm
immunofluoresc
stain
use
specif
monoclon
antibodi
five
group
nest
multiplex
pcr
assay
target
respiratori
virus
three
bacteria
appli
five
group
virus
outer
inner
set
primer
sequenc
amplicon
size
list
tabl
primer
design
base
modifi
publish
primer
sequenc
construct
consensu
region
obtain
genbank
aliquot
cellfre
supernat
spun
nasopharyng
aspir
use
extract
rna
dna
qiaamp
minelut
viru
spin
kit
qiagen
hong
kong
pcr
perform
use
fast
thermal
cycler
appli
biosystem
foster
citi
ca
dna
polymeras
fast
pcr
master
mix
geneamp
appli
biosystem
firstround
secondround
pcr
conduct
reaction
l
complementari
dna
templat
aliquot
firstround
pcr
product
firstround
secondround
pcr
respect
cycl
condit
round
pcr
initi
denatur
cycl
denatur
annealingextens
follow
final
extens
adenoviru
detect
cycl
denatur
use
instead
cultur
stock
target
pathogen
use
posit
control
cultur
stock
avail
clinic
specimen
known
contain
target
agent
use
spirometri
bronchodil
vitalograph
buckingham
uk
perform
month
discharg
hospit
ie
stabl
copd
accord
american
thorac
societi
standard
updat
predict
spirometri
valu
hong
kong
chines
adopt
patient
contact
telephon
medic
record
review
month
later
check
death
hospit
readmiss
data
analyz
use
statist
softwar
spss
version
spss
chicago
il
associ
identif
viru
npa
episod
aecopd
lung
function
clinic
outcom
patient
mortal
nppv
use
length
hospit
stay
assess
mann
whitney
u
test
test
fisher
exact
test
appropri
data
present
mean
sd
p
consid
signific
altogeth
episod
aecopd
screen
studi
case
n
pneuwwwchestjournalorg
chest
septemb
aaaacaartgctctgcrccycaac
crtctccacctacttcrttyccccc
monic
chang
cxr
predominantli
congest
heart
failur
exclud
among
case
fit
inclus
criteria
patient
refus
consent
studi
final
episod
aecopd
includ
analysi
among
patient
subject
return
lung
function
test
day
discharg
hospit
aecopd
thirteen
subject
die
either
inpati
discharg
lung
function
test
could
arrang
wherea
subject
default
followup
among
die
default
followup
lung
function
data
obtain
stabl
state
within
year
prior
admiss
aecopd
taken
statist
analysi
data
avail
deceas
subject
default
major
subject
men
length
stay
acut
care
hospit
day
first
episod
hospit
aecopd
patient
die
wherea
patient
readmit
hospit
anoth
episod
aecopd
within
month
among
episod
aecopd
episod
requir
nppv
support
neither
icu
admiss
invas
mechan
ventil
requir
subject
demograph
data
subject
present
tabl
among
npa
specimen
collect
subject
posit
viral
pcr
result
common
viru
identifi
influenza
patient
follow
coronaviru
patient
rhinoviru
patient
influenza
b
patient
respiratori
syncyti
viru
rsv
patient
result
viral
etiolog
base
pcr
assay
shown
figur
influenza
belong
subtyp
neither
subtyp
identifi
four
case
parainfluenza
virus
detect
one
case
follow
strain
identifi
parainfluenza
type
tabl
show
pcr
result
npa
relat
lung
function
subject
rate
identifi
posit
viral
etiolog
pcr
similar
among
subject
fev
predict
normal
season
pattern
virus
illustr
figur
rate
posit
viru
identif
pcr
method
npa
peak
juli
septemb
year
among
subject
admit
aecopd
receiv
influenza
vaccin
within
past
month
differ
detect
rate
influenza
b
npa
compar
without
influenza
vaccin
vs
p
relationship
influenza
vaccin
detect
rate
influenza
virus
npa
pcr
method
shown
tabl
altogeth
episod
aecopd
pcr
convent
viral
cultur
perform
viral
identif
npa
wherea
viral
cultur
perform
patient
comparison
convent
viral
cultur
overal
diagnost
yield
pcr
approxim
three
time
higher
comparison
pcr
convent
viral
cultur
npa
specimen
shown
tabl
npa
pcrposit
viral
cultureposit
case
n
longer
length
hospit
stay
case
n
posit
pcr
neg
viral
cultur
result
day
vs
day
p
howev
lung
function
fev
percentag
predict
valu
two
group
show
signific
differ
vs
p
episod
aecopd
posit
viral
identif
compar
without
length
hospit
stay
similar
median
day
interquartil
rang
day
day
interquartil
rang
day
virusposit
virusneg
group
respect
p
signific
differ
rate
hospit
readmiss
virusposit
virusneg
group
initi
admiss
virusposit
group
viru
neg
group
p
oneyear
mortal
rate
virusposit
vs
virusneg
group
also
similar
virusposit
group
virusneg
group
p
furthermor
differ
rate
nppv
usag
virusposit
virusneg
group
vs
respect
p
best
knowledg
first
largescal
prospect
studi
conduct
asia
viral
etiolog
patient
hospit
aecopd
use
sensit
techniqu
pcr
respiratori
specimen
influenza
coronaviru
rhinoviru
common
virus
identifi
subject
wherea
pcr
techniqu
viral
identif
base
npa
speci
comparison
studi
diagnost
yield
virus
use
pcr
techniqu
rel
lower
might
due
geograph
differ
viral
etiolog
aecopd
differ
site
respiratori
specimen
collect
respiratori
virus
identifi
nasal
sampl
east
london
copd
cohort
aecopd
manag
outpati
set
studi
german
patient
sever
aecopd
requir
hospit
respiratori
virus
detect
nasal
sampl
wherea
diagnost
yield
induc
sputum
even
higher
recent
studi
patient
sever
exacerb
necessit
intub
mechan
ventil
viral
agent
identifi
respiratori
specimen
obtain
via
endotrach
tube
studi
viral
etiolog
among
patient
hospit
nearfat
asthma
endotrach
aspir
patient
acut
asthma
induc
sputum
patient
copd
induc
sputum
singapor
influenza
viru
identifi
subject
hospit
aecopd
studi
use
sputum
pcr
improv
knowledg
viral
etiolog
aecopd
local
ambient
air
pollut
may
also
lead
aecopd
assess
studi
although
rhinoviru
detect
episod
hospit
studi
common
viral
pathogen
identifi
studi
aecopd
rhinoviru
major
caus
common
cold
commun
increas
evid
rhinoviru
may
directli
infect
lower
airway
patient
copd
sampl
lower
airway
secret
addit
upper
airway
may
lead
higher
diagnost
yield
virus
studi
common
viru
identifi
influenza
viru
might
due
rel
low
influenza
vaccin
rate
studi
compar
east
london
cohort
hong
kong
predomin
circul
strain
influenza
recent
year
patient
aecopd
proven
influenza
infect
studi
strain
identifi
previou
studi
unit
state
report
virul
hospit
admiss
chest
infect
relat
death
significantli
higher
influenza
preval
similar
studi
studi
aecopd
also
identifi
rhinoviru
coronaviru
influenza
b
viru
parainfluenza
viru
rsv
adenoviru
subject
although
percentag
vari
differ
studi
human
metapneumoviru
identifi
one
episod
aecopd
studi
wherea
studi
report
low
detect
rate
induc
sputum
npa
sampl
respect
found
evid
pneumonia
c
pneumonia
infect
observ
consist
previou
studi
appear
patient
posit
npa
pcr
posit
viral
cultur
result
sever
exacerb
evidenc
longer
length
stay
hospit
posit
npa
pcr
neg
viral
cultur
result
result
might
suggest
virus
npa
patient
posit
npa
pcr
viral
cultur
result
activ
replic
thu
result
sever
aecopd
longer
hospit
stay
note
two
peak
respiratori
viral
fig
infect
copd
patient
studi
period
year
observ
influenza
season
springwint
period
consist
oversea
studi
anoth
local
studi
second
peak
influenzalik
ill
summer
current
studi
aecopd
patient
requir
hospit
also
line
season
influenza
gener
commun
hong
kong
signific
differ
rate
posit
pcr
result
npa
copd
patient
receiv
influenza
vaccin
past
month
wongsurakiat
et
al
previous
show
aecopd
defin
symptom
studi
influenzarel
acut
respiratori
ill
confirm
serolog
test
viral
cultur
respiratori
secret
requir
hospit
could
decreas
influenza
vaccin
current
recommend
global
initi
chronic
obstruct
lung
diseas
gold
guidelin
annual
influenza
vaccin
offer
copd
patient
elderli
subject
gener
commun
specif
copd
subject
studi
found
influenza
vaccin
could
halv
incid
serolog
clinic
influenza
reduc
util
hospit
resourc
howev
subject
receiv
influenza
vaccin
could
protect
antibodi
respons
studi
wongsurakiat
et
al
approxim
subject
antibodi
respons
influenza
influenza
b
respect
studi
need
assess
efficaci
annual
influenza
vaccin
role
booster
dose
copd
patient
limit
studi
singlecent
studi
although
hospit
serv
larg
popul
million
due
limit
resourc
patient
recruit
everi
altern
day
although
demograph
patient
repres
whole
group
compar
previou
studi
addit
patient
stabl
state
copd
recruit
control
subject
thu
sure
whether
virus
identifi
npa
true
pathogen
repres
colon
chronic
infect
previou
studi
use
pcr
techniqu
could
identifi
virus
includ
piconaviru
influenza
b
viru
parainfluenaza
rsv
respiratori
specimen
stabl
copd
patient
rate
virus
identif
patient
stablest
copd
much
lower
aecopd
rsv
infect
patient
copd
associ
symptomat
respiratori
ill
togeth
measur
immun
respons
highli
like
viral
infect
play
import
role
trigger
aecopd
conclus
identifi
virus
pcr
techniqu
npa
specimen
aecopd
episod
requir
hospit
common
virus
influenza
coronaviru
rhinoviru
viral
infect
appear
effect
subsequ
readmiss
rate
mortal
rate
studi
period
year
differ
rate
viral
infect
among
copd
patient
differ
gold
stage
recent
year
grow
epidemiolog
evid
link
virus
aecopd
worth
note
coronaviru
rhinoviru
fastidi
growth
cover
routin
diagnost
spectrum
servic
laboratori
data
shown
coronaviru
rhinoviru
could
also
exacerb
copd
studi
diagnost
therapeut
vaccin
trivial
virus
need
addit
explor
mechan
virus
may
induc
aecopd
